Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(3)

Detailed Status

Completed3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

completed3100%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Post-occlusive Reactive Hyperemia and Basal-cell Carcinoma

NCT01455363
completed

Use of Laser Speckle to Study Post Occlusive Reactive Hyperhemia in Healthy Subjects

NCT01169974
completed

Use of Laser Speckle to Study Cutaneous Blood Flow at Exercise in Healthy Subjects

NCT01152008

Clinical Trials (3)

Showing 3 of 3 trials
NCT01455363Not Applicable

Post-occlusive Reactive Hyperemia and Basal-cell Carcinoma

Completed
NCT01169974

Use of Laser Speckle to Study Post Occlusive Reactive Hyperhemia in Healthy Subjects

Completed
NCT01152008

Use of Laser Speckle to Study Cutaneous Blood Flow at Exercise in Healthy Subjects

Completed

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3